FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/02/050000 [Registered on: 22/02/2023] Trial Registered Prospectively
Last Modified On: 21/02/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Role of Homoeopathic medicines in the treatment of cases of tinea corporis (Fungal) 
Scientific Title of Study   Usefulness of individualized homoeopathic medicine in centesimal potency vis a vis LM potency in the treatment of tinea corporis: A comparative observational study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Abhishek Gautam 
Designation  PG Scholar 
Affiliation  Bakson homoeopathic medical college & hospital 
Address  Department of homoepathic materia medica Room number S2 2nd Floor Bakson Homoeopathic Medical College and Hospital 36B phase 1 Knowledge Park Greater Noida Gautam Buddha Nagar
NIL
Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  8174070130  
Fax    
Email  gautam8174@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Abhishek Gautam 
Designation  PG Scholar 
Affiliation  Bakson homoeopathic medical college & hospital 
Address  Department of homoepathic materia medica Room number S2 2nd Floor Bakson Homoeopathic Medical College and Hospital 36B phase 1 Knowledge Park Greater Noida Gautam Buddha Nagar
NIL
Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  8174070130  
Fax    
Email  gautam8174@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ashwini Nair  
Designation  PG Incharge Guide HOD Department of Homoeopathic Materia Medica 
Affiliation  Bakson Homoeopathic Medical College and Hospital 
Address  Post Graduation Cell Room number G21 Ground floor Bakson Homoeopathic Medical College and Hospital 36B phase 1 Knowledge Park Greater Noida Gautam Buddha Nagar
NA
Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  9990178024  
Fax    
Email  ashraj1974@gmail.com  
 
Source of Monetary or Material Support  
Bakson homoeopathic medical college and hospital 
 
Primary Sponsor  
Name  Bakson Homoeopathic Medical college and hospital 
Address  Bakson Homoeopathic Medical College and Hospital Room No G 22 Ground Floor 36B phase 1 Knowledge Park Greater Noida Gautam Buddha Nagar 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Not applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Abhishek Gautam  Bakson Homoeopathic Medical College and Hospital  Bakson Homoeopathic Medical College and Hospital Room No G 22 Ground floor 36B phase 1 Knowledge park 1 Greater Noida Gautam Buddha Nagar
Gautam Buddha Nagar
UTTAR PRADESH 
8174070130

gautam8174@gmail.com 
Abhishek Gautam  Dr. D P Rastogi Central Research Institiute for Homoeopathy  A 1/1 Opposite HCL Sector 24 Noida
Gautam Buddha Nagar
UTTAR PRADESH 
8174070130

gautam8174@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional Ethical Committee, Bakson Homoeopathic Medical College   Approved 
Kendriya Homoeopathic Anusandhan Parishad  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B354||Tinea corporis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathic medicine in Centesimal potency  Pill Form Globule No 30 Route of Administration oral Centesimal potency first dose at the beginning of case. repetition according to follow up. follow ups every 2 weeks for a period of 24 weeks. 
Intervention  Homoepathic Medicine in LM Potency  Oral route of administration liquid form (water as vehicle) in 100ml bottle 1 teaspoon is taken as 1st dose 1st dose will be given after case taking repetition according to foollow up follow up every 2 weeks for a period of 24 weeks.  
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  19.00 Year(s)
Age To  59.00 Year(s)
Gender  Both 
Details  1 Patient with the age group of 19 years to 59 years
2 Diagnostic criteria will be mainly based on clinical history, presentation and examination with the help of KOH test.
3 Patient taking prior medications or topical creams will be enrolled after wash out periods of 15 days  
 
ExclusionCriteria 
Details  1 Pregnant and lactating women.
2 Patient having tinea infection secondary to other complications like lichenification.
3 Immune suppressed patients with HIV or on chemotherapy  
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Expected reduction in 5 D Pruritus scale   5 D Pruritus score will be done at baseline, 4 weeks, 8 weeks and 12 weeks.  
 
Secondary Outcome  
Outcome  TimePoints 
NIL  Not applicable 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/03/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is randomized, open label, double arm trial, comparing the usefulness of individualized homoeopathic   centesimal potency and LM potency in the management of Tinea corporis. The primary outcome will be to compare the changes in the lesions of Tinea corporis with individualized homoeopathic medicines in  centesimal potency and LM potency using 5D Pruritus scale. 5D Pruritus Scale will be used at the baseline, and at the end of treatment or final follow up and the scores in both the groups will be compared and concluded accordingly. 
Close